TY - JOUR T1 - Refined risk stratification in pulmonary arterial hypertension and timing of lung transplantation JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.03087-2021 VL - 60 IS - 2 SP - 2103087 AU - Karen M. Olsson AU - Manuel J. Richter AU - Jan C. Kamp AU - Henning Gall AU - Hossein-Ardeshir Ghofrani AU - Jan Fuge AU - Ralf Ewert AU - Marius M. Hoeper Y1 - 2022/08/01 UR - http://erj.ersjournals.com/content/60/2/2103087.abstract N2 - In patients with pulmonary arterial hypertension (PAH) presenting with progressive disease despite optimised medical therapy, lung transplantation remains an important treatment option [1–3]. Current guidelines recommend assessing the individual mortality risk regularly using a three-stratum model to determine whether patients are at low, intermediate or high risk of death [1, 2].The four-stratum risk assessment tool helps determining the right time for lung transplant listing in patients with pulmonary arterial hypertension https://bit.ly/3GrLSId ER -